Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2000
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063236A2 Adhesion modulatory peptides and methods for use
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063228A1 Ent-steroids as selectively active estrogens
10/26/2000WO2000063221A2 Galectin 11
10/26/2000WO2000063218A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063202A2 BENZO[b] THIOPHENE SULFONAMIDE-1, 1-DIOXIDE DERIVATIVES AND THEIR USE AS ANTINEOPLASTIC AGENTS
10/26/2000WO2000063197A1 Hydroxamic acid derivative
10/26/2000WO2000063194A1 Sulfonamide derivatives having oxadiazole rings
10/26/2000WO2000063191A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063180A1 Bis-benzazoles and their use as antineoplastic agents
10/26/2000WO2000063178A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000062818A1 Differentiation of monocytes into functional dendritic cells
10/26/2000WO2000062813A2 Cationic peg-lipids and methods of use
10/26/2000WO2000062809A1 Proliferation inhibitor for androgen-independent tumor
10/26/2000WO2000062808A2 Cobalamin conjugates useful as antitumor agents
10/26/2000WO2000062807A1 Diagnosis and treatment of neuroectodermal tumors
10/26/2000WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/26/2000WO2000062789A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/26/2000WO2000062779A1 Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062770A1 Compounds useful as phosphotyrosine mimics
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000062765A2 ESTROGEN RECEPTOR-β LIGANDS
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000062735A2 Treatment of neoplasms with viruses
10/26/2000WO2000062657A2 Improvement of t cell mediated immunity
10/26/2000WO2000047607B1 A synthetic peptide disturbing intracellular signaling
10/26/2000WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof
10/26/2000WO2000039120A3 Compounds and methods for modulation of estrogen receptors
10/26/2000WO2000039082A3 1,2-annelated quinoline derivatives
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000WO2000035865A3 Tubulin-binding agents
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000028045A3 Human hydrolase proteins
10/26/2000WO2000026197A9 Novel inhibitors of impdh enzyme
10/26/2000WO2000025808A8 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
10/26/2000WO2000019976A9 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them
10/26/2000WO2000018795A3 Compositions and methods for wt1 specific immunotherapy
10/26/2000WO2000018230A9 Combination of bisphosphonate and tetracycline
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000WO2000007577A3 Phosphatidylcholine as a medicament for the protection of mucosa
10/26/2000WO2000006206A9 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/26/2000DE19918434A1 Storage-stable solid proton pump inhibitor formulation useful e.g. for treating duodenal ulcers, comprises amorphous active agent embedded in auxiliary matrix
10/26/2000DE19918365A1 New nucleic acid encoding flavone synthase II, useful e.g. for producing transgenic plants with altered flower color or flavone content
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/26/2000CA2371611A1 Galectin 11
10/26/2000CA2370945A1 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000CA2370690A1 Cationic peg-lipids and methods of use
10/26/2000CA2370628A1 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000CA2370617A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000CA2370419A1 Cobalamin conjugates useful as antitumor agents
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370296A1 Improvement of t cell mediated immunity
10/26/2000CA2370146A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000CA2370142A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2370126A1 Estrogen receptor-.beta. ligands
10/26/2000CA2369961A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity
10/26/2000CA2369820A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000CA2369342A1 Carbohydrate-modifying enzymes
10/26/2000CA2368029A1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000CA2367395A1 Cyclic amine derivatives and use thereof
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2365949A1 Adhesion modulatory peptides and methods for use
10/26/2000CA2365449A1 Inhibitor of the growth of androgen-independent tumor
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2363689A1 Compounds useful as phosphotyrosine mimics
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1046400A1 Methods and compositions for treating human cells
10/25/2000EP1045907A1 Dkr polypeptides
10/25/2000EP1045906A1 Apo-2 ligand
10/25/2000EP1045897A1 Enzyme catalyzed therapeutic agents
10/25/2000EP1045863A1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers
10/25/2000EP1045861A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
10/25/2000EP1045853A1 Synthesis of combretastatin a-4 prodrugs and trans-isomers thereo f
10/25/2000EP1045846A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045698A1 Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
10/25/2000EP1045689A1 Synthesis of phenstatin and prodrugs thereof
10/25/2000EP1045688A1 Lipomatrix preparation
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271391A Methods and compositions for therapies using genges encoding secreted proteins such as interferon-beta
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/25/2000CN1271361A Tetrazole-containing rapamycin analogs with shortened half-lives
10/25/2000CN1271355A Heterocyclic compounds and antitumor agent containing the same as active ingredient
10/25/2000CN1271349A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/25/2000CN1271347A 1,5-diphenylpypazole derivatives
1 ... 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 ... 2211